Minerva Neurosciences, Inc. (NERV) research

Minerva Neurosciences, Inc.

Sector: Healthcare
Industry: Biotechnology
Last price: $3.81
As of: 2026-09-22

Minerva Neurosciences, Inc. (NERV): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-12.

As of 2026-08-16, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest signal other than 13F-derived signals. Source: SEC EDGAR filings for NERV. Method and limitations.

LIVE TERMINAL

See NERV live in the terminal

Track NERV's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live NERV terminal, free

Active signals for NERV

mediumEARNINGS_MISS2026-08-12
Q2-2026: Missed consensus by 44.9%, EPS $-0.17 vs $-0.1173 estimate
All 2026-08-12 signals →
mediumEARNINGS_MISS2026-06-20
Q4-2025: Missed consensus by 109.2% - EPS $-0.64 vs $-0.306 estimate
All 2026-06-20 signals →
mediumEARNINGS_BEAT2026-06-20
Q2-2025: Beat consensus by 53.2% - EPS $-0.43 vs $-0.918 estimate
All 2026-06-20 signals →
mediumEARNINGS_MISS2026-05-31
Q1-2026: Missed consensus by 31.6% - EPS $-0.17 vs $-0.1292 estimate
All 2026-05-31 signals →
mediumEARNINGS_MISS2026-05-31
Missed consensus by 109.2% - EPS $-0.64 vs $-0.306 estimate
All 2026-05-31 signals →

FREE, NO ACCOUNT

Every signal on NERV, as it fires

You are seeing 5 of 7 signals recorded on NERV since 2026-05-31.

The five above landed across 3 days. The other 2 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in NERV (2026Q2)

Manager / security	Market value	% portfolio	QoQ
MILLENNIUM MANAGEMENT LLCCUSIP 603380205 · 2026Q2	$3M	0.00%	,
RENAISSANCE TECHNOLOGIES LLCCUSIP 603380205 · 2026Q2	$407K	0.00%	,
TWO SIGMA INVESTMENTS, LPCUSIP 603380205 · 2026Q2	$142K	0.00%	,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, NERV

8-K2026-08-12
SEC EDGAR ↗
10-Q2026-08-07
SEC EDGAR ↗
8-K2026-08-07
SEC EDGAR ↗
8-K2026-06-04
SEC EDGAR ↗
8-K2026-05-27
SEC EDGAR ↗
8-K2026-05-05
SEC EDGAR ↗
10-Q2026-05-05
SEC EDGAR ↗
8-K2026-04-06
SEC EDGAR ↗
8-K2026-04-02
SEC EDGAR ↗
8-K2026-03-11
SEC EDGAR ↗

Related tickers

See more NERV signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to NERVand get the insider, 13F, options, and confluence read in one view.